Covista, the new name for Adtalem Global Education Inc., announced its rebranding and the adoption of the ticker symbol CVSA on the New York Stock Exchange, effective February 24, 2026. The change follows a four‑year transformation that has positioned the company as America’s largest healthcare educator, serving more than 97,000 students across five accredited institutions.
In its Q2 FY2026 earnings, Covista reported revenue of $503.4 million, up 12.4% year‑over‑year, and GAAP net income of $76.4 million. Adjusted earnings per share reached $2.43, beating consensus estimates of $2.19 by $0.24. The beat was driven by a 6.3% enrollment increase to 97,000 students, disciplined cost management, and a favorable mix shift toward higher‑margin programs and AI‑enabled learning initiatives.
Management raised its full‑year adjusted EPS guidance to $7.80–$8.00 from the prior $7.50–$7.70 range, reflecting confidence in continued enrollment growth, the monetization of AI‑powered platforms, and sustained cost discipline. Revenue guidance was also increased, underscoring the company’s belief that the healthcare education market will expand faster than previously expected.
Covista launched the Covista Care Capacity Monitor, a research platform that quantifies workforce shortages using data collected in a November 2025 survey. The initiative, part of the Covista Open Doors impact commitment, provides actionable insights for health systems and policymakers and reinforces Covista’s role as a critical infrastructure provider in the U.S. healthcare workforce ecosystem.
The company will host an Investor Day on February 24, 2026 to outline growth targets, capital allocation plans, and its partnership with Google Cloud and Hippocratic AI to expand AI‑enabled credentialing for healthcare professionals.
Following the earnings release, the market reacted with a modest after‑hours decline of 1.16%. Investors appeared cautious, weighing valuation concerns and broader macro conditions, even as the company’s fundamentals—strong revenue growth, margin expansion, and a raised guidance—signal robust execution and a clear strategic focus.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.